ATP5IF1 and Parkinson disease: In the present study, we found that treatment with IF1 protects mitochondria from PD-like insults and prevents depletion of energy, loss of mitochondrial potential, accumulation of ROS, and activation of apoptotic signaling in dopaminergic cells in vitro.